Screening for Lipid Disorders in Children and Adolescents: An Evidence Update for the U.S. Preventive Services Task Force [Internet]

Review
Rockville (MD): Agency for Healthcare Research and Quality (US); 2023 Jul. Report No.: 22-05301-EF-1.

Excerpt

To systematically review evidence for the effectiveness and harms of screening and treatment of pediatric dyslipidemia due to FH and multifactorial dyslipidemia.

Publication types

  • Review

Grants and funding

Prepared for: Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services, 5600 Fishers Lane, Rockville, MD 20857; www.ahrq.govContract No. 75Q80120D00004, Task Order: 75Q80120F32001Prepared by: Kaiser Permanente Evidence-based Practice Center, Kaiser Permanente Center for Health Research, Portland, OR